Skip to main content

Month: March 2026

THC Therapeutics, Inc. Announces Filing of 10-K and Provides Corporate Update

JACKSBORO, Texas, March 03, 2026 (GLOBE NEWSWIRE) — THC Therapeutics, Inc. (OTC: THCT), a dynamic and growing cannabis company, issued a shareholder update today. To our valued friends and shareholders, We hope that this letter finds you well. We at THCT continue to execute our revitalized strategy and are pleased to provide a corporate update, highlighting our achievements to date and our vision for the future. Corporate Highlights: With the recent acquisitions, we believe the Company’s current trading price does not yet reflect the underlying value of our operating businesses and assets. We attribute this disconnect primarily to our Expert Market status. As we complete our filings and return to a fully current reporting position, we expect improved visibility, expanded market access, and more efficient price discovery. Our objective...

Continue reading

Intuitive Machines Selected by L3Harris to Support SDA Proliferated Warfighter Space Architecture Tranche 3 Tracking Layer

HOUSTON, March 03, 2026 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines” or the “Company”), a leading space technology, infrastructure, and services company, today announced Lanteris Space Systems, a wholly owned subsidiary of Intuitive Machines, was selected by L3Harris Technologies (NYSE: LHX) to support the development and production of spacecraft platforms for the Space Development Agency (“SDA”) Tranche 3 Tracking Layer of the Proliferated Warfighter Space Architecture. Under this selection, Intuitive Machines will design, build and deliver 18 advanced spacecraft platforms to help enable the next generation of space-based missile tracking capabilities. This effort supports the SDA mission to deliver persistent, real-time tracking of advanced missile threats, including hypersonic and ballistic...

Continue reading

Global Mofy Recognized in the 2025 Chinese Listed Companies Brand 500

BEIJING, March 03, 2026 (GLOBE NEWSWIRE) — Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider focused on virtual content production and digital content industrialization, today announced that it has been named to the “2025 Chinese Listed Companies Brand 500” at the 2025 China Economic Summit Forum and the 7th Chinese Listed Companies Brand 500 Release Conference. According to data released at the conference, the aggregate brand value of companies included in the “2025 Chinese Listed Companies Brand 500” reached RMB 42.03 trillion, with the average brand value increasing to RMB 8.4053 billion. Technology, finance, and energy companies formed the leading segment of the ranking, while manufacturing accounted for the largest number of companies represented, with...

Continue reading

February Sales Stabilize as Higher Ticket Sizes Offset Weather Driven Foot Traffic Declines

Fiserv Small Business Index remains at 143; year-over-year sales grew +1.2% MILWAUKEE, March 03, 2026 (GLOBE NEWSWIRE) — Fiserv, Inc. (NASDAQ: FISV), a leading global provider of payments and financial services technology, has published the Fiserv Small Business Index for February 2026, indicating that higher average tickets and shifting winter demand drove small business sales up slightly in February. The seasonally adjusted Index remained at 143. Year-over-year sales grew (+1.2%) despite transactions (foot traffic) slowing (-0.8%) year over year. Month-over-month sales (+0.2%) and foot traffic (-0.1%) changed little compared to January. Sales growth was largely driven by higher tickets, which grew both year over year (+2.0%) and month over month (+0.3%). “Small businesses showed resilience in February, with sales seeing a modest...

Continue reading

Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates

— On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 — — Ongoing engagement with FDA for PM359 in CGD; plan to submit BLA following final alignment — — Prime Medicine reported cash, cash equivalents, investments, and restricted cash of $191M providing cash runway into 2027 — CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today reported financial results for the full year ended December 31, 2025 and provided a business update. “We are shaping the future of genetic medicine by advancing a platform that is rapidly emerging as the predominant...

Continue reading

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended December 31, 2025 and Declaration of Distributions on Common Stock for the Months Ending April 30, May 31, and June 30, 2026

GREENWICH, Conn., March 03, 2026 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQH) (the “Company,” “we,” “us” or “our”) announced today its financial results and related information for the quarter ended December 31, 2025.On February 26, 2026, our Board of Directors declared the following distributions on our common stock:Month Ending Record Date Payment Date Amount Per ShareApril 30, 2026 April 16, 2026 April 30, 2026 $0.035May 31, 2026 May 15, 2026 May 29, 2026 $0.035June 30, 2026 June 16, 2026 June 30, 2026 $0.035       Net asset value (“NAV”) per share as of December 31, 2025 stood at $1.69, compared with a NAV per share on September 30, 2025 of $1.95.Net investment income (“NII”) was approximately $5.4 million, or $0.07 per share, for the quarter ended...

Continue reading

Village Super Market, Inc. Reports Results for the Second Quarter Ended January 24, 2026

SPRINGFIELD, N.J., March 03, 2026 (GLOBE NEWSWIRE) — Village Super Market, Inc. (NSD-VLGEA) today reported its results of operations for the second quarter ended January 24, 2026. Second Quarter of Fiscal 2026 HighlightsNet income of $17.9 million, an increase of 6% compared to $16.9 million in the second quarter of the prior year Sales increased 6.9% and same store sales increased 4.8% Same store digital sales increased 15%Year-To-Date Fiscal 2026 HighlightsNet income of $29.9 million, an increase of 1% compared to $29.7 million in the prior year-to-date period Adjusted net income of $30.1 million, an increase of 1% compared to adjusted net income of $29.7 million in the prior year-to-date period Sales increased 5.7% and same store sales increased 3.7% Same store digital sales increased 15%Second Quarter of Fiscal 2026...

Continue reading

Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in Potential Royalties and Milestones upon execution of a Definitive Agreement

The Collaboration Framework marks Adial’s first step towards commercial partnership and establishing an exclusive European pathway as AD04 advances toward pivotal Phase 3 development GLEN ALLEN, Va., March 03, 2026 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction and related disorders, today announced it has entered into a collaboration framework agreement with Molteni Farmaceutici (“Molteni”) for a proposed exclusive partnership covering the commercialization of AD04 in Europe. The collaboration framework, which is subject to execution of a final definitive agreement, sets forth the strategic and financial parameters of the planned partnership, covering clinical, regulatory, manufacturing,...

Continue reading

Eldorado Gold’s Lamaque Complex Receives TSM Gold Leadership Award; Certified in Full Compliance with International Cyanide Code Management

VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (TSX: ELD, NYSE American: EGO)  (“Eldorado” or the “Company”) is pleased to announce that its Lamaque Complex in Val‑d’Or, Québec has received the Towards Sustainable Mining (TSM) Gold Leadership Award from the Mining Association of Canada (MAC) in recognition of its outstanding performance in responsible mining.The TSM Gold Leadership Award recognizes mining operations that achieve Level AAA – the highest possible rating – across all applicable TSM performance indicators, as verified by independent external auditors. The Lamaque Complex earned Level AAA across its applicable indicators, reflecting excellence in the operations sustainability practices. Only five other facilities have received this recognition to date, and this is the first...

Continue reading

Journal of Analytical Toxicology Publishes Peer-Reviewed Validation Study Demonstrating Accuracy of Omega Laboratories’ Test Method for Detecting Marijuana in Breath Samples Using Cannabix Technologies’ Breath Collection Unit

VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) and Omega Laboratories Inc (“Omega”) proudly announce the peer-reviewed publication of a groundbreaking study published by Oxford University Press in the prestigious Journal of Analytical Toxicology titled: “Simultaneous Analysis of Δ9-THC, Δ8-THC, CBD, and CBN in Breath Aerosols Collected Using Cannabix Technologies Breath Collection Unit.” This marks a major milestone in the advancement of marijuana breath testing technology globally. The study demonstrates the accuracy and utility of Omega Laboratories’ analytical method for detecting cannabinoids in breath samples collected using Cannabix Technologies’ Breath Collection Unit and Breath Cartridges—further validating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.